Targeting Hsp90: Development of small molecule C-terminal inhibitors

被引:0
|
作者
Anyika, Mercy [1 ]
Blagg, Brian [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
84-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Hsp90 C-Terminal Inhibitors Exhibit Antimigratory Activity by Disrupting the Hsp90α/Ahal Complex in PC3-MM2 Cells
    Ghosh, Suman
    Shinogle, Heather E.
    Garg, Gaurav
    Vielhauer, George A.
    Holzbeierlein, Jeffrey M.
    Dobrowsky, Rick T.
    Blagg, Brian S. J.
    ACS CHEMICAL BIOLOGY, 2015, 10 (02) : 577 - 590
  • [32] The C-terminal half of Hsp90 is responsible for its cytoplasmic localization
    Passinen, S
    Valkila, J
    Manninen, T
    Syvälä, H
    Ylikomi, T
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (20): : 5337 - 5342
  • [33] Design and synthesis of small molecule inhibitors of the Hsp90 chaperone.
    Chiosis, G
    Timaul, MN
    Sepp-Lorenzino, L
    Zheng, FZF
    Lucas, B
    Danishefsky, SJ
    Rosen, N
    CLINICAL CANCER RESEARCH, 2000, 6 : 4495S - 4495S
  • [34] Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone
    Batista, Fernanda A. H.
    Ramos, Sergio L., Jr.
    Tassone, Giusy
    Leitao, Andrei
    Montanari, Carlos A.
    Botta, Maurizio
    Mori, Mattia
    Borges, Julio C.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 639 - 649
  • [35] Strategy of Virtual Screening based Discovery of HSP90 C-terminal Inhibitors and Network Pharmacological Analysis
    Li, Lihong
    Yang, Man
    Li, Chenyao
    Xue, Hongyu
    Shi, Meiyun
    Liu, Yajun
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (14) : 1637 - 1646
  • [36] Discovery of novel Hsp90 C-terminal domain inhibitors that disrupt co-chaperone binding
    Mak, Oi Wei
    Sharma, Nabangshu
    Reynisson, Johannes
    Leung, Ivanhoe K. H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 38
  • [37] C-terminal Hsp90 inhibitors restore glucocorticoid sensitivity in an experimental model for Cushing's disease
    Riebold, M.
    Theodoropoulou, M.
    Kozany, C.
    Hausch, F.
    Stalla, G. K.
    Paez-Pereda, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [38] Exploiting Conformational Dynamics in Drug Discovery: Design of C-Terminal Inhibitors of Hsp90 with Improved Activities
    Moroni, Elisabetta
    Zhao, Huiping
    Blagg, Brian S. J.
    Colombo, Giorgio
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (01) : 195 - 208
  • [39] Design and biological testing of peptidic dimerization inhibitors of human Hsp90 that target the C-terminal domain
    Bopp, Bertan
    Ciglia, Emanuele
    Ouald-Chaib, Anissa
    Groth, Georg
    Gohlke, Holger
    Jose, Joachim
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (06): : 1043 - 1055
  • [40] N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes
    Wang, Y.
    McAlpine, S. R.
    CHEMICAL COMMUNICATIONS, 2015, 51 (08) : 1410 - 1413